Literature DB >> 11086174

Expression of receptor-Ck and SREBP genes in mononuclear cells from acute leukemia patients.

N Varma1, S Varma, D Kaul.   

Abstract

We have recently shown that Receptor-Ck regulated genes, involved in cellular growth and death through a transcriptional factor (SREBP) which has affinity for sterol regulatory element (SRE) present in the promoter region of these genes. The present study revealed that blasts, derived from both ALL and AML patients, were unable to express SREBP gene product although they had the capacity to express Receptor-Ck gene product. These results which depict defective Receptor-Ck-dependent signalling are in conformity with our previous results which showed that lymphocytes from CML patients as well as other human leukemic cell lines are unable to express gene coding for Receptor-Ck leading again to a state of impaired Receptor-Ck-dependent signalling. On the basis of these results, we propose that deregulated Receptor-Ck-dependent signalling may have an important role in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086174     DOI: 10.1016/s0145-2126(00)00055-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Functional genomics of PPAR-gamma in human immunomodulatory cells.

Authors:  Deepak Kaul; Paras K Anand; Amit Khanna
Journal:  Mol Cell Biochem       Date:  2006-04-22       Impact factor: 3.396

2.  Importance of LXR-alpha transcriptome in the modulation of innate immunity.

Authors:  Deepak Kaul; Ankur Gautam; Kavleen Sikand
Journal:  Mol Cell Biochem       Date:  2006-06-07       Impact factor: 3.396

3.  Effect of herbal polyphenols on atherogenic transcriptome.

Authors:  Deepak Kaul; Akshay R Shukla; Kavleen Sikand; Veena Dhawan
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

4.  Receptor-Ck regulates membrane-bound 125 kDa protein having affinity for genomic sterol regulatory sequence.

Authors:  D Kaul; M Kaur
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.